vs

Side-by-side financial comparison of Medirom Healthcare Technologies Inc. (MRM) and REGIS CORP (RGS). Click either name above to swap in a different company.

REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $21.1M, roughly 2.7× Medirom Healthcare Technologies Inc.). REGIS CORP runs the higher net margin — 0.8% vs -21.3%, a 22.1% gap on every dollar of revenue. REGIS CORP produced more free cash flow last quarter ($891.0K vs $-2.4K).

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.

MRM vs RGS — Head-to-Head

Bigger by revenue
RGS
RGS
2.7× larger
RGS
$57.1M
$21.1M
MRM
Higher net margin
RGS
RGS
22.1% more per $
RGS
0.8%
-21.3%
MRM
More free cash flow
RGS
RGS
$893.4K more FCF
RGS
$891.0K
$-2.4K
MRM

Income Statement — Q2 2025 vs Q2 2026

Metric
MRM
MRM
RGS
RGS
Revenue
$21.1M
$57.1M
Net Profit
$-4.5M
$456.0K
Gross Margin
Operating Margin
-28.5%
10.8%
Net Margin
-21.3%
0.8%
Revenue YoY
22.3%
Net Profit YoY
-94.0%
EPS (diluted)
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRM
MRM
RGS
RGS
Q4 25
$57.1M
Q3 25
$59.0M
Q2 25
$21.1M
$60.4M
Q1 25
$57.0M
Q4 24
$46.7M
Q3 24
$46.1M
Q2 24
$49.4M
Q1 24
$49.2M
Net Profit
MRM
MRM
RGS
RGS
Q4 25
$456.0K
Q3 25
$1.4M
Q2 25
$-4.5M
$116.5M
Q1 25
$250.0K
Q4 24
$7.6M
Q3 24
$-853.0K
Q2 24
$91.2M
Q1 24
$-2.3M
Operating Margin
MRM
MRM
RGS
RGS
Q4 25
10.8%
Q3 25
10.0%
Q2 25
-28.5%
12.1%
Q1 25
8.8%
Q4 24
11.8%
Q3 24
4.6%
Q2 24
Q1 24
8.3%
Net Margin
MRM
MRM
RGS
RGS
Q4 25
0.8%
Q3 25
2.3%
Q2 25
-21.3%
192.9%
Q1 25
0.4%
Q4 24
16.4%
Q3 24
-1.9%
Q2 24
184.7%
Q1 24
-4.7%
EPS (diluted)
MRM
MRM
RGS
RGS
Q4 25
$0.16
Q3 25
$0.49
Q2 25
$43.67
Q1 25
$0.08
Q4 24
$2.71
Q3 24
$-0.36
Q2 24
$38.40
Q1 24
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRM
MRM
RGS
RGS
Cash + ST InvestmentsLiquidity on hand
$252.3K
$18.4M
Total DebtLower is stronger
$8.8M
$113.3M
Stockholders' EquityBook value
$1.6M
$188.7M
Total Assets
$52.0M
$588.3M
Debt / EquityLower = less leverage
5.55×
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRM
MRM
RGS
RGS
Q4 25
$18.4M
Q3 25
$16.6M
Q2 25
$252.3K
$17.0M
Q1 25
$13.3M
Q4 24
$10.2M
Q3 24
$6.3M
Q2 24
$10.1M
Q1 24
$5.9M
Total Debt
MRM
MRM
RGS
RGS
Q4 25
$113.3M
Q3 25
$111.3M
Q2 25
$8.8M
$110.8M
Q1 25
$112.0M
Q4 24
$111.5M
Q3 24
$95.2M
Q2 24
$99.5M
Q1 24
$179.7M
Stockholders' Equity
MRM
MRM
RGS
RGS
Q4 25
$188.7M
Q3 25
$187.6M
Q2 25
$1.6M
$185.6M
Q1 25
$68.6M
Q4 24
$66.7M
Q3 24
$56.4M
Q2 24
$56.8M
Q1 24
$-35.8M
Total Assets
MRM
MRM
RGS
RGS
Q4 25
$588.3M
Q3 25
$592.1M
Q2 25
$52.0M
$599.0M
Q1 25
$511.2M
Q4 24
$530.1M
Q3 24
$508.9M
Q2 24
$530.5M
Q1 24
$543.7M
Debt / Equity
MRM
MRM
RGS
RGS
Q4 25
0.60×
Q3 25
0.59×
Q2 25
5.55×
0.60×
Q1 25
1.63×
Q4 24
1.67×
Q3 24
1.69×
Q2 24
1.75×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRM
MRM
RGS
RGS
Operating Cash FlowLast quarter
$-2.3K
$1.7M
Free Cash FlowOCF − Capex
$-2.4K
$891.0K
FCF MarginFCF / Revenue
-0.0%
1.6%
Capex IntensityCapex / Revenue
0.0%
1.4%
Cash ConversionOCF / Net Profit
3.65×
TTM Free Cash FlowTrailing 4 quarters
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRM
MRM
RGS
RGS
Q4 25
$1.7M
Q3 25
$2.3M
Q2 25
$-2.3K
$6.8M
Q1 25
$6.2M
Q4 24
$2.1M
Q3 24
$-1.3M
Q2 24
$5.1M
Q1 24
$-277.0K
Free Cash Flow
MRM
MRM
RGS
RGS
Q4 25
$891.0K
Q3 25
$1.9M
Q2 25
$-2.4K
$6.2M
Q1 25
$5.9M
Q4 24
$1.7M
Q3 24
$-1.4M
Q2 24
$5.1M
Q1 24
$-326.0K
FCF Margin
MRM
MRM
RGS
RGS
Q4 25
1.6%
Q3 25
3.2%
Q2 25
-0.0%
10.3%
Q1 25
10.3%
Q4 24
3.6%
Q3 24
-3.0%
Q2 24
10.3%
Q1 24
-0.7%
Capex Intensity
MRM
MRM
RGS
RGS
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.0%
0.9%
Q1 25
0.6%
Q4 24
0.9%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
MRM
MRM
RGS
RGS
Q4 25
3.65×
Q3 25
1.68×
Q2 25
0.06×
Q1 25
24.80×
Q4 24
0.28×
Q3 24
Q2 24
0.06×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRM
MRM

Segment breakdown not available.

RGS
RGS

Franchise Segment$37.9M66%
Royalty$13.6M24%
Other$2.8M5%
Fees$1.8M3%
Franchise Fees$1.0M2%

Related Comparisons